Product Description

CMTA1 Polyclonal Antibody

Sizes: 20μL, 50μL, 100μL

Catalogue Numbers: BT-AP15034-20, BT-AP15034-50, BT-AP15034-100

Citations, Manuals and MSDS Available upon request.

Background: disease:Defects in CAMTA1 are detected in patients with oligodendroglioma and astrocytoma.,Transcriptional activator. May act as a tumor suppressor.,induction:Detected at low levels at interphase and in resting cells. Up-regulated during S-phase and mitosis. Levels decrease at the end of mitosis.,Belongs to the CAMTA family.,Contains 1 CG-1 DNA-binding domain.,Contains 1 IPT/TIG domain.,Contains 3 ANK repeats.,Contains 3 IQ domains.,subunit:May interact with calmodulin .,tissue specificity:Detected in whole brain, cerebellum, brain cortex, occipital lobe, frontal lobe, temporal lobe, putamen, heart and kidney. Detected in neuroblastic-type cultured neuroblastoma cells.,

Research Areas: Cancer; Epigenetics and nuclear

Target Protein: CAMTA1

Applications: WB, ELISA

Reactivity: Human, Mouse

Clonality: Polyclonal

Host: Rabbit

Isotype: IgG

Full Product Name: Calmodulin-binding transcription activator 1

Immunogen: The antiserum was produced against synthesized peptide derived from human AMPK alpha around the phosphorylation site of Thr172. AA range:140-189

Storage: -20°C for 1 year

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Formulation: Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Concentration: 1 mg/ml

UniProt Accession: Human: Q9Y6Y1; Mouse: A2A891

Synonyms: Calmodulin-binding transcription activator 1

GeneID: Human: 23261

Research Use Only